Dreismann Heinrich has filed 5 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 45000 shares of MAINZ BIOMED N.V. ($MYNZ) on February 13, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 13, 2026 | MAINZ BIOMED N.V. | $MYNZ | Dreismann Heinrich | Director | A | Ordinary Shares | 45000 | $0.00 | 64,700.0000 | 2,319,353 | 228.43% | 1.94% |
| June 5, 2025 | MYRIAD GENETICS INC | $MYGN | Dreismann Heinrich | Director | A | Common Stock | 49796 | $0.00 | 171,444.0000 | 91,309,064 | 40.93% | 0.05% |
| Sept. 9, 2024 | MYRIAD GENETICS INC | $MYGN | Dreismann Heinrich | Director | S | Common Stock | 10000 | $27.05 | 121,648.0000 | 0 | 7.60% | 0.00% |
| June 6, 2024 | MYRIAD GENETICS INC | $MYGN | Dreismann Heinrich | Director | A | Common Stock | 15695 | $0.00 | 131,648.0000 | 0 | 13.54% | 0.00% |
| June 1, 2023 | MYRIAD GENETICS INC | $MYGN | Dreismann Heinrich | Director | A | Common Stock | 15151 | $0.00 | 115,953.0000 | 0 | 15.03% | 0.00% |